參考文獻/References:
[1] 張鑫,劉波,劉輝,等.骨質疏松癥的診斷標準及其相關影響因素[J].中醫(yī)正骨,2012,24(3):33-35.
[2] Godoy Monzón D,Iserson KV,Jauregui J,et al.Total hip arthroplasty for hip fractures:5-year follow-up of functional outcomes in the oldest Independent old and very old patients[J].Geriatr Orthop Surg Rehabil,2014,5(1):3-8.
[3] 中華醫(yī)學會骨質疏松和骨礦鹽疾病分會.原發(fā)性骨質疏松癥診治指南[J].中國骨質疏松雜志,2011,8(3):2.
[4] 宣淼,楊軍,李穎,等.唑來膦酸與替勃龍對絕經后骨質疏松癥骨密度、骨代謝指標及骨折影響的臨床研究[J].中華內分泌代謝雜志,2013,29(6):504-508.
[5] Chao M,Hua Q,Yingfeng Z,et al.Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women[J].Pak J Med Sci,2013,29(6):1381-1384.
[6] Khajuria DK,Razdan R,Mahapatra DR.Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats[J].J Orthop Sci,2014,19(4):646-656.
[7] 黃建武,黃建華,林愛菊.補腎健骨湯合阿倫磷酸鈉對絕經后骨質疏松癥患者骨密度和性激素水平的影響[J].中醫(yī)正骨,2013,25(8):30-31.
[8] 林華,徐天舒,范璐,等.5mg唑來膦酸治療絕經后骨質疏松及其骨折[J].中華創(chuàng)傷骨科雜志,2012,14(1):31-35.
[9] Li CY,Mori S,Li JL,et al.Long-term effect of incadronate disodium(YM-175)on fracture healing of femoral shaft in growing rats[J].J Bone Mineral Research,2001,16(3):429-436.
[10] Sahana H,Khajuria DK,Razdan R,et al.Improvement in bone properties by novel nanoparticle based formulation in a rat model of osteporosis[J].J Biomed Nanotechnol,2013,9(2):193-201.
[11] 聶海,彭超,郝杰,等.唑來膦酸預防絕經婦女骨質疏松性骨折的meta分析[J].第二軍醫(yī)大學學報,2011,32(9):985-990.
[12] Briot K,Cortet B,Thomas T,et al.2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis[J].Joint Bone Spine,2012,79(3):304-313.
[13] 郭艾,羅先正,任素梅,等.股骨假體周圍骨密度定量測定[J].中國骨質疏松雜志,1999,5(3):28.
[14] Shen Y,Li XM,Ding YR,et al.Stro-1-positive BMSCs predict postoperative periprosthetic bone mineral density outcomes in uncemented total hip arthroplasty patients[J].Med Sci Monit,2014,20:361-367.
[15] 王博,李玉雄.抗骨疏膠囊治療原發(fā)性骨質疏松癥的臨床研究[J].中醫(yī)正骨,2010,22(5):21-23.
相似文獻/References:
[1]潘雄,劉其順,應行,等.中藥聯合4步康復鍛煉法對骨質疏松性椎體壓縮
骨折患者生存質量的影響[J].中醫(yī)正骨,2015,27(04):65.
[2]吳鵬,王博,孔令成,等.強骨飲顆粒聯合阿侖膦酸鈉維D3片口服在原發(fā)性骨質疏松性髖部骨折術后抗骨質疏松治療中的應用[J].中醫(yī)正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(強骨飲顆粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):16.
[3]陳建德,樊曉琦,夏炳江,等.球囊擴張部位對椎體后凸成形術治療骨質疏松性椎體壓縮骨折療效及安全性的影響[J].中醫(yī)正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(01):11.
[4]史曉林,王健,王博,等.脆性骨折的防治進展[J].中醫(yī)正骨,2017,29(05):20.
[5]朱麗英,胡春艷,孟苗,等.唑來膦酸靜脈滴注聯合華蟾素膠囊口服治療轉移性骨腫瘤[J].中醫(yī)正骨,2017,29(07):55.
[6]陳勍,劉鐘,陳文亮,等.股骨近端防旋髓內釘固定聯合口服仙靈骨葆膠囊治療腎陽虛型骨質疏松性股骨轉子間骨折[J].中醫(yī)正骨,2017,29(07):69.
[7]曾武,林曙峰,朱俊峰,等.女性骨質疏松性橈骨遠端骨折鎖定鋼板內固定術后腕關節(jié)功能恢復的影響因素分析[J].中醫(yī)正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(01):39.
[8]丁志清,顏峰,喻燦明,等.椎體后凸成形術后非典型骨水泥植入綜合征死亡1例[J].中醫(yī)正骨,2017,29(11):76.
[9]漆繼聰,喻丹.唑來膦酸聯合左歸丸在預防人工全髖關節(jié)置換術后假體無菌性松動中的應用[J].中醫(yī)正骨,2018,30(01):62.
[10]俞興,王婷,楊濟洲,等.經皮椎體成形術和經皮椎體后凸成形術治療Kmmell病的對比研究[J].中醫(yī)正骨,2018,30(06):23.
YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(01):23.